NCT05848973

Brief Summary

University students in Low- and Middle-Income Countries (LMIC) continue to face growing rates of depression, a common mental health problem. Adding to this burden is the mental health treatment gap, necessitating the need to identify new treatment methods that can easily be implemented at a large scale. This project will test if a healthy diet combined with mindfulness-based cognitive therapy can reduce depressive symptoms among university students in Uganda, a low resource country. The burden of depression is high in sub-Saharan African countries, largely worsened by poverty, hunger and poor public health service, and lately the COVID-19 pandemic. These factors increase psychological distress among young people in sensitive periods of life, such as students who are about to choose their career and establish family. Successfully managing depression in LMIC is likely to depend on low-cost treatment that can easily be managed to large target populations, yet still be at the scientific forefront, proof-based, and culturally acceptable. This can possibly be obtained with an intervention combining healthy diet and cognitive behavioral therapy based on mindfulness principles. While healthy diets and mindfulness cognitive therapy individually can partly lessen the burden of depression, these two therapeutic modalities have not been tested in combination among university students in sub-Saharan Africa, i.e. a synergistic effect that is still to be studied. With the NutriMind Trial, its investigators focus on a neglected global mental health challenge, namely depression among university students in Uganda.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for not_applicable depression

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 8, 2023

Completed
8 months until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

May 9, 2024

Status Verified

May 1, 2024

Enrollment Period

2 years

First QC Date

March 27, 2023

Last Update Submit

May 7, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline to 24 months in depressive symptoms using the Center for Epidemiological Studies - Depression (CES-D) score among the study participants randomized to each of the three intervention arms compared with the controls.

    Depressive symptoms will be assessed using the CES-D score from before to after the intervention. CES-D scores range from 0 to 60, with higher scores indicating greater depressive symptoms. The CES-D provides cut-off scores (16 or greater) to aid in identifying individuals at risk for clinical depression, with good sensitivity and specificity and high internal consistency.

    24 months

Secondary Outcomes (8)

  • Change from baseline to 24 months in depressive symptoms using the Beck Depression Inventory-II (BDI-II) score among the study participants randomized to each of the three intervention arms compared with the controls.

    24 months

  • The health economic costs of each of the three intervention arms compared with the control group.

    24 months

  • Change from baseline to 24 months in body weight among the study participants randomized to each of the three intervention arms compared with the controls.

    24 months

  • Change from baseline to 24 months in body height among the study participants randomized to each of the three intervention arms compared with the controls.

    24 months

  • Change from baseline to 24 months in body composition among the study participants randomized to each of the three intervention arms compared with the controls.

    24 months

  • +3 more secondary outcomes

Study Arms (4)

Healthy diet

ACTIVE COMPARATOR

The study participants randomized to this arm will be given advice about consuming a healthy diet, i.e. a diet rich in vegetables/fruits and wholegrain/fibre, fish, olive oil; and moderate in red meat and dairy products. The participants will receive 8 weekly, one hour group sessions delivered by trained nutritionists.

Other: Healthy Diet

Mindfulness-based cognitive therapy (MBCT)

ACTIVE COMPARATOR

The study participants randomized to this arm will be taught the purpose and application of MBCT, namely to modify cognitive and effective processes in the management of depressive symptoms as well as relapse prevention among those with residual depressive symptoms. It is a structured 8-weeks' intervention program delivered in groups, with an all-day practice session around week six and regular reunion sessions thereafter.

Behavioral: Mindfulness-based cognitive therapy (MBCT)

Healthy diet and MBCT combined

ACTIVE COMPARATOR

The study participants randomized to this arm will receive both the healthy diet intervention and the MBCT intervention

Other: Healthy DietBehavioral: Mindfulness-based cognitive therapy (MBCT)

Control

NO INTERVENTION

No particular intervention will be provided to the control group.

Interventions

The targeted study participants will be given advice about healthy dietary intakes. This will entail promotion of foods rich in vegetables/fruits and wholegrain/fibre, fish, olive oil; moderate in lean red meat and low-fat diary products). To be concrete, the study investigators will target energy (E%) from macronutrients as follows: 42 E% total fat (≥ 22 E% from monounsaturated fatty acids, 10 E% from polyunsaturated fatty acids and \<10 E% saturated fatty acids), 35 E% carbohydrate, 15 E% protein and ≤ E 5% alcohol. Importantly, this will meet all Recommended Dietary Intake requirements for adults.

Healthy dietHealthy diet and MBCT combined

MBCT is a skills-based intervention comprising a structured 8-week group intervention program to be delivered in groups of study participants, with an all-day practice session around week six and regular reunion sessions thereafter.

Healthy diet and MBCT combinedMindfulness-based cognitive therapy (MBCT)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Those who score between 16 and 25 on the CES-D scale
  • Completed \>1 study-year of study and have \>2 study-years before graduation
  • Not using any medication regularly that might interfere with study adherence or - outcomes
  • Giving consent to participate

You may not qualify if:

  • Not being diagnosed with chronic disorder or cancer
  • Not being pregnant
  • Not having food allergy- or intolerance
  • Not having experienced recent bereavement or major personal loss (e.g. income or divorce)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Makerere University

Kampala, Central Uganda, +26, Uganda

RECRUITING

Related Publications (1)

  • Kardel KR, Iversen PO, Kaaya AN, Muhoozi G, Veierod MB, Wangen KR, Borosund E, Friberg PA. A pragmatic randomized trial to examine the effect of combining healthy diet with mindfulness cognitive therapy to reduce depressive symptoms among university students in a low-resource setting: protocol for the NutriMind Project. BMC Psychiatry. 2024 Sep 11;24(1):610. doi: 10.1186/s12888-024-06056-9.

MeSH Terms

Conditions

Depression

Interventions

Diet, HealthyMindfulness-Based Cognitive Therapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

DietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaMindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Prudence A Friberg

    University of Bergen

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Prudence A Friberg, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The data collection teams will be blinded to the allocation arms throughout the trial in order to minimise measurement bias.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The NutriMind trial will include three intervention groups, namely; the healthy diet group, the psychotherpay group (Mindfulness-Based Cognitive Therapy-MBCT), a combined healthy diet and MBCT group and a control group with no intervention. Pending the financial situation investigators may also consider having two arms: Intervention (Diet and MBCT) and control.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 27, 2023

First Posted

May 8, 2023

Study Start

January 1, 2024

Primary Completion

December 30, 2025

Study Completion

December 30, 2025

Last Updated

May 9, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

Informed Consent Form (ICF) will be shared with all study participants and was approved by Uganda Institutional Review Board. Clinical Study Report (CSR) will be published on the trial website that is going to be created during the study. There is signed Material Transfer Agreement (MTA) between the collaborating universities that specifies data sharing process

Shared Documents
STUDY PROTOCOL, ICF, CSR
Time Frame
Approximately 3 years from the start of the study.When all collected data has been analysed and published the results in an open access journal.
Access Criteria
Project website that will be established when the study implementation starts

Locations